menu
    • menu

    Company profile for Anocca

    NEW Drugs in Dev: 1
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Anocca is a privately held Swedish biotechnology company founded in 2014 with the mission to establish a unique technology platform for analysis of T-cell biology to unlock the therapeutic potential of T-cell immunity. Anocca’s technologies enable the highly precise and efficient analysis of T-cell biology required to deliver a range of therapeutics that specifically harness or manipulate T-cell immunity in a number of dise...
    Anocca is a privately held Swedish biotechnology company founded in 2014 with the mission to establish a unique technology platform for analysis of T-cell biology to unlock the therapeutic potential of T-cell immunity. Anocca’s technologies enable the highly precise and efficient analysis of T-cell biology required to deliver a range of therapeutics that specifically harness or manipulate T-cell immunity in a number of disease areas.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AnoccaSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Forskargatan 20C 151 36 Södertälje
    Telephone
    Telephone
    +46 (0)8 410 807 50
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.anocca.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/anocca-ab?originalSubdomain=se
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    IMCAS Asia

    IMCAS Asia

    Not Confirmed

    envelop Contact Supplier

    IMCAS Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Anocca Doses First Patients With KRAS-Targeting TCR-T Therapy
    Anocca Doses First Patients With KRAS-Targeting TCR-T Therapy

    11 Jun 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260611280382/en/Anocca-has-Dosed-First-Patients-with-Precision-TCR-T-Cell-Therapy-Targeting-Mutant-KRAS-in-Pancreatic-Cancer

    BUSINESSWIRE
    11 Jun 2026
    Share Share
    Anocca Raises SEK 440M to Advance Pancreatic Cancer Trial
    Anocca Raises SEK 440M to Advance Pancreatic Cancer Trial

    18 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250818046061/en/Anocca-Raises-SEK-440-Million-to-Advance-Clinical-Trial-Targeting-Pancreatic-Cancer

    BUSINESSWIRE
    18 Aug 2025
    Share Share
    Anocca Raises $46 M for Pancreatic Cancer Trial
    Anocca Raises $46 M for Pancreatic Cancer Trial

    18 Aug 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/anocca-raises-46m-to-advance-clinical-trial-targeting-pancreatic-cancer/

    CONTRACTPHARMA
    18 Aug 2025
    Share Share
    MaxCyte, Anocca AB Partner for Advancement of TCR-T Cell Therapy
    MaxCyte, Anocca AB Partner for Advancement of TCR-T Cell Therapy

    31 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/31/3124964/0/en/MaxCyte-Announces-Strategic-Platform-Licensing-Agreement-with-Anocca-AB-to-Advance-TCR-T-Cell-Therapy-Pipeline.html

    GLOBENEWSWIRE
    31 Jul 2025
    Share Share
    Anocca Authorises Clinical Trial for Advanced Pancreatic Cancer
    Anocca Authorises Clinical Trial for Advanced Pancreatic Cancer

    17 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/17/3043419/0/en/Anocca-Announces-Authorisation-of-Clinical-Trial-Application-to-Start-First-In-Human-Trial-in-Advanced-Pancreatic-Cancer.html

    GLOBENEWSWIRE
    17 Mar 2025
    Share Share
    Anocca Submits Trial Application for VIDAR-1 in Pancreatic Cancer
    Anocca Submits Trial Application for VIDAR-1 in Pancreatic Cancer

    26 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/26/2987214/0/en/Anocca-Announces-Submission-of-Clinical-Trial-Application-for-Multi-asset-Trial-VIDAR-1-in-Advanced-Pancreatic-Cancer.html

    GLOBENEWSWIRE
    26 Nov 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search